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Abstract
Background: The South African Tuberculosis Vaccine Initiative is based in Worcester where tuberculosis (TB)
is endemic, and incidence rates are amongst the highest nationally. In high TB burden settings after an early
childhood peak, incidence rates start to rise again in adolescents, therefore they are an important target group
for tuberculosis vaccine research. In 2012, learners from a local school developed a one-off theatrical production
out of an educational comic book Carina’s Choice, developed by the South African Tuberculosis Vaccine Initiative
in 2010. A Wellcome Trust International Engagement grant allowed for this one-off production to be further
developed, with input from university students and staff, and rolled out to schools in the Worcester area as an
engagement and education intervention.
Methods: Focus group feedback was used to identify key messages and to develop the play’s script. Qualitative
methods were used to collect and analyse relevant data. Interviews were conducted with learner-actors, pre- and
post-focus group feedback was obtained from a sample of school-going adolescents, and pre- and post-questionnaires
were administered to adolescent audience members.
Results: From the pre-drama focus group discussions, topics such as TB symptoms, stigma and transmission were
identified as areas that needed attention. After the performances, adolescents showed improved knowledge on the
identified topics and they discussed TB prevention measures. They highlighted transmission of TB during pregnancy
as a further topic to be addressed in future iterations of the drama. Although stigma is a difficult phenomenon to
interpret, post-drama participants understood that TB transmission could occur in all individuals. Learner-actors agreed
with focus group participants that the play could impact the wider community if it were rolled out. Feedback from the
South African Tuberculosis Vaccine Initiative staff verified that recruitment for an upcoming trial was facilitated by the
preparedness that the play provided in recruitment areas. The study showed that before and after evaluations provide
data on the usefulness of the play as an education tool.
Conclusions: Theatre, presented and motivated by adolescent peers, can raise awareness of TB, and assist clinical trial
preparedness and further engagement between trial staff and their trial community.
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Background
Adolescents are one of the primary target populations
for new tuberculosis (TB) vaccination strategies in high
TB burden settings because incidence rates start to rise
again in adolescents (after the established early child-
hood peak). The increased incidence in late adolescence
makes this age group an important target for TB vaccine
and related social science research [1]. Efforts to engage
with adolescents to ensure that they are fully informed
about TB, vaccine trials and their rights and responsibil-
ities with respect to clinical research are imperative.
Valuable data becomes available when such efforts are
combined with assessments of their effectiveness, not
only in terms of education and awareness, but also in
terms of overall knowledge, attitudes and perceptions
about the disease in question. Although interactive
methods such as role playing, video games and group
work are increasingly being used in health awareness
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raising interventions, knowledge about their effective-
ness is still limited [2].
Researchers at the South African Tuberculosis Vaccine
Initiative (SATVI) have conducted two TB vaccine trials
in adolescents in a semi-rural, high TB burden commu-
nity in the Western Cape, South Africa, since 2005 and
are currently conducting a TB vaccine trial with 990
high school learners. By way of continuous engagement
with people in the immediate areas surrounding their
site, SATVI ensures that potential trial participants are
prepared for recruitment processes and that they are
educated about TB and on their rights and responsibil-
ities in clinical trials.
A community engagement project funded by a Stop
TB grant assisted this aim in the form of a comic,
Carina’s Choice, which was developed by SATVI with
input from staff and the Community Advisory Board in
2010. Carina’s Choice is a story of a young mother justi-
fying her decision to enrol her infant into a TB vaccine
trial to her family and friends. Upon its dissemination,
the comic received positive feedback, including the inde-
pendent decision by a local arts-focused school, Worcester
Secondary School (WSS), to dramatise the comic using
high school pupils as performers, stage managers, and
light and sound engineers. The positive reception of the
single performance of this dramatisation led SATVI
researchers to explore funding opportunities to support
further development of the drama, and its wider roll-out.
With the awarding of a Wellcome Trust International
Engagement Grant, the drama’s further development and
subsequent assessments of its impact were made possible.
This paper describes the process for developing Carina’s
Choice into a play and it reports on the play’s impact as a
method of engagement for TB and clinical trials.
Methods
The most recent dramatisation of the comic, Carina’s
Choice, by high school learners involved collaboration
with the University of Cape Town (UCT) Drama School
and WSS. The Carina’s Choice roadshow took place in
the third quarter of 2013, with 12 performances at eight
high schools to a total audience of about 7500 adoles-
cents. The performers, WSS drama pupils, were selected
by their teacher to participate in the drama production.
A production team was formed with representatives
from WSS, SATVI and UCT Drama School to be re-
sponsible for script development, skills development,
production of the play including video-recording, and
project management. Senior UCT drama students, su-
pervised by a faculty member of the UCT Drama School,
provided guidance to school pupils through the various
stages of drama production. The language used in the
play was a colloquial, slang Afrikaans, including English
words and phrases. The play consisted of age- and area-
appropriate humour, and song, rap and dance elements.
The key messages for the drama production were chosen
using the Carina’s Choice comic and then validated
against pre- and post-focus group input. The planned
key messages on initialising the project, and prior to any
community engagement, are presented in Table 1.
The analysis in this paper relies on qualitative methods.
Feedback workshops were conducted with pupils who
acted in the play (student-actors). Pre- and post-focus
group discussions took place with a sample of learners,
while pre- and post-knowledge assessment question-
naires were administered to all learners attending the
performance.
Pre- and post-drama focus groups (ranging from 8 to
15 members), a central tool in this project’s effort for
continuous evaluation, were conducted by a social scien-
tist and translator at the SATVI office. Focus group
participants were drawn from three schools in the
Worcester area, representing the linguistic diversity of
the region (English, Afrikaans and isiXhosa). The schools
were chosen based on their representing all three lan-
guages spoken in the area as well as drawing children
from both higher income and middle to low income back-
grounds. Participants were selected by a random selection
of names from a list of adolescents who had previously
expressed an interest in TB vaccine research activities,
using a random number generating online tool. Each
school group met separately once before and once after
the play. Focus group questions were based on the pro-
duction’s main themes, with the aim of determining topics
of local importance related to TB and to explore TB
knowledge, attitudes and perceptions amongst adolescents
in Worcester.
The study protocol was approved by the UCT Human
Research Ethics Committee and permission to conduct
the project in the local high schools was obtained from
the Department of Education. Written informed consent
and assent for focus group participation were obtained
by SATVI staff members in the adolescent’s home
language or language of choice along with permission
to audio-record the group sessions. Focus groups met
at the SATVI project office after school hours. The
groups were semi-structured with participatory exercises
Table 1 Initial key messages of the drama production
TB symptoms and actions to take when symptoms persist
TB can be treated
There is a need for a new, more effective TB vaccine
SATVI is doing clinical research to test new vaccines
Strong emphasis on safety and ethical conduct because new TB
vaccines are tested in people
Participants have rights in clinical research
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(including pile-sorting [3] and a graffiti wall – see [4] for
an explanation of the graffiti wall), and a pre-developed
script allowing for adaptation of content and duration ac-
cording to the responses received. Focus groups were
audio-recorded for transcription later.
Pre-intervention focus groups were convened with the
intention of identifying gaps in current knowledge and
understanding, to inform the content of the script. Post-
intervention focus groups were used to identify where
gaps in information might still exist in the script, to
evaluate the learners’ responses to the play and to deter-
mine where future engagement and information dissem-
ination might be usefully focused. Written informed
consent of those who participated in the pre- and post-
intervention focus groups was obtained by recruiters
from SATVI in the language that students preferred.
The production toured eight high schools in the Cape
Winelands East district: six in Worcester, and one each
in Rawsonville and Robertson, chosen for proximity to
SATVI and therefore, logistic ease, as well as being the
planned recruitment schools of an adolescent TB vac-
cine trial. In addition, after the production had toured at
eight schools, the learner-actors forming the production
joined in informal and formal discussions about their
experiences on the project. Parents of learner-actors
were asked to give consent before they participated in
the production. Assent was obtained from leaner-actors
before focus group discussions and then, at the closing
of these discussions, verbal confirmation was obtained
for their inputs to be used for research purposes. The
transcripts from the formal discussions also formed part
of the evaluation process, as did feedback from SATVI
clinical staff in the form of informal conversations and
emails.
Adolescent audience members completed a pre- and
post-drama questionnaire to evaluate their knowledge of
TB and clinical research, drawn from validated survey
questionnaires [5–8]. Parents and guardians were in-
formed of the upcoming production and knowledge
assessments through a take-home letter and given the
opportunity to return a slip to opt out of their child’s
participation in this survey – no parent took this oppor-
tunity. All surveys remained anonymous.
Data collection
All interviews and focus group discussions were audio-
recorded, translated, transcribed and data coded. Written
records created during the sessions were retained as hard
copies. Photographs were taken of images created using
participatory methods during the focus groups and stored
digitally. Field notes, as the responsibility of individual
researchers, were password protected. Additionally, know-
ledge survey questionnaires were anonymous with no
identifiers other than basic demographics of age, gender
and school grade. These were collected by the school ap-
proximately one week after the performance and captured
on an access-restricted Microsoft Access database.
Data analysis
Transcripts from focus group discussions and hard-copy
documents from the “graffiti wall” and pile-sorting ac-
tivities in focus groups were reviewed for emerging
themes and coded inductively. A code list was gener-
ated to identify the emergent codes and sub-codes for
analysis. Coding was done by two independent re-
viewers (AA and BS).
Results
Pre-drama focus groups
The scriptwriters were given feedback about the data
that resulted from analysis of the pre-play focus group
discussions. Additional messages were then added to the
script (Table 2) and to a pre-specified list of key messages
generated prior to engagement from previous research in
the area [9].
From the pre-drama focus groups, it was evident that
coughing was a known symptom of TB. This informa-
tion was incorporated in the redevelopment of the
script, so that the play developed with students’ input.
For example, the rewrite of the script included a focus
on what to do when someone coughed. The first song of
the play states “maak daai vensters oop; hoes in jou
elmboog,” which is an instruction on coughing into the
elbow and opening windows to increase air circulation.
Only a few adolescents could name more than one
symptom of TB, but none were able to name all of the
symptoms. Thus, the production team ensured that the
play worked on raising awareness of other symptoms of
TB, including fatigue and weight loss.
Pre-drama focus group interviews also revealed that
local knowledge on transmission of TB was limited.
Questions like “You can only transfer it through your
Table 2 Topics for clarification in the production as per
pre-drama focus group interviews
Differences between TB and HIV, and their association
Cause of TB
Different types of TB
Personal protection against community TB
Information dissemination and education about TB
TB reactivation and TB reinfection
Defining stigma and addressing it
Transmission of TB
Symptoms of TB, aside from coughing
The absence of TB symptoms
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spit, right?” juxtaposed with “You can get it from sex” or
“What about sharing cigarettes?”, showed that the trans-
mission of TB, as well as how TB differed from HIV
needed to be clarified in the play. Focus group
participants confused the transmission vectors of TB
and HIV, thinking that TB was transmitted sexually, as
was HIV. This conflation of the two diseases was clari-
fied to learner-actors during production workshops, and
to the audience in the play. In fact, a specific rap song
explaining the difference between TB and HIV was
written by the learner-actors and performed in the play
(see Table 3).
When focus group participants were asked directly
about TB-related stigma, many responded that they
either did not understand the term “stigma” or that they
did not think that it existed. However, proceeding dis-
cussions and comments, presented in Table 4, revealed
that TB was in fact highly stigmatised and there were
misconceptions about those with TB disease.
Recurring questions around the safety of sharing, for
example sharing a drink or cigarette, with someone who
has TB were reminiscent of fears associated with the
early days of HIV. Associations between TB and HIV
may cause speculation of HIV amongst those who have
TB. A high TB–HIV co-infection rate may lead to confu-
sions in biomedical processes of TB and HIV, and also
in everyday language. For example, “I might be a carrier”
was mentioned by one of the participants suspecting TB,
since “carrier” in biomedicine is used to refer to individ-
uals with HIV infection or other diseases. Another quote
again brings to light that HIV stigma is displayed in the
context of TB: “But people are ashamed because people
outside are going to say, oh, you have HIV and AIDS. So
people are ashamed of that, so they will not go to clinic
[when they suspect TB].” Nonetheless, TB stigma was
also observed outside the realm of HIV terminology,
where reference was made to “farm people” (people
working on a farm) as most likely having TB.
Often in the context of stigma, blame for spreading
TB and blame for destabilising family income is present
[10]. Participants expressed that those with TB had to be
concerned about transmitting it to other family mem-
bers and there was a clear acknowledgement that the
household income was affected, this being attributed to
the infected family member. Hence, an interesting no-
tion of “running away from TB” emerged from the focus
group discussions. In the presence of stigmatisation and
blame, participants described that many people with TB
would not accept their diagnosis or they would not
adhere to medication regimens or even collect their
medications. Others would hide their positive TB diag-
nosis from the public (that is, by “hiding away their
medicine under their beds”).
A primary aim of Carina’s Choice was to raise aware-
ness within the Worcester community that patients, as
well as clinical trial participants, have rights. From the
pre-drama focus group discussions, it became evident
that participants were not vulnerable, and in fact, knew
“that they had rights to confidentiality”. Adolescent par-
ticipants set the pace for discussions and determined the
method of engagement. For example, one participant
with agreement from peers asked: “Can we get to the
point? I don’t literally mean to the point; I mean can we
get to the next question.” Another participant, when she
felt everyone had enough of a chance to answer a discus-
sion question would exclaim, “OK, next question!” The
discussion also confirmed that misconceptions about
vaccines and the role of SATVI existed. Participants
thought that “SATVI is vaccinating people not to get
TB” and that vaccinations from SATVI “stop you from
getting TB, so we can talk to someone who has TB, but
Table 3 Rap song explaining the difference between TB and
HIV
Now with a lack of sanitation and poor ventilation
With the hubbly going round and round
You can get the V
That’s TB, not H-I-V.
But while we’re on the subject, always use a rubber
Cos unprotected sex could make you a mother (or father!)
So guard yourself against HIV
Take part in the trials with SATVI
And help us with the fight against TB.
Table 4 Comments by participants during pre-drama focus
group discussions
What must people do when they have TB and when people are talking
bad things about TB? Some people are saying bad things about them.
Some people keep it a secret when they are infected with TB.
Because they don’t know if you have TB, so they talk to you and they
touch you. When they find out that you have TB, they don’t want you
anymore.
Because they feel … how can I say this now … they feel that they are
not equal to others because they have this virus.
But sometimes you get people who are like, don’t touch me, you have
TB.
They are like avoiding you, and don’t touch me.
Or they say **, don’t speak with them.
Don’t go to that girl, she’s dirty.
I think it’s the ** type of illness that they’re hiding because of what they
heard. So that is why it’s making it difficult for people to take their
medicine.
Ja, that’s very important. Because you were saying that sometimes
people don’t like the people with TB. They say go away, and they don’t
want to eat with you.
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we can’t get TB”. Clearing up such misconceptions was
already listed as a priority of the play.
Post-drama focus groups
In the pre-drama focus group discussions, participants
only named coughing as a symptom of TB. The discus-
sions revealed that the spread of TB is visualised as
coughing and that stigma is practised against a coughing
suspect. In fact, coughing was a prominent symptom of
TB mentioned by focus group participants. However,
participants could list other symptoms such as fatigue,
night sweats and weight loss after attending the play.
Even though participants conflated TB and HIV in the
initial discussions, they could differentiate the spread of
TB and HIV in the post-drama discussions. For example,
participants could explain that “HIV is something you
get when you have sex, but TB is in the air.”
The questions posed in the pre-drama focus groups
relating to transmission of TB were raised again, and led
to a discussion about the ways in which adolescents
could protect themselves against TB, through opening
windows and seeking diagnosis and treatment early.
Some participants could also make links between the
symptoms of TB and progression of the disease: “If you
feel that you are coughing a lot and you are feeling tired,
go to the hospital to be sure … get it treated.” Focus
group participants said that they remembered most of
the information they learned from the play through the
songs that were performed. For example, one participant
remembered to be cautious of coughing from the lyrics
of a song “Hoes en koes”, presented in the Appendix,
which was performed during the play.
Although stigma is not an easy phenomenon to inter-
pret, post-drama focus group participants revealed that
they learned that TB transmission is possible to all
individuals regardless of socio-economic characteristics.
Participants recognised that there was a change in com-
munity attitudes towards TB-diseased individuals, but it
was not clear whether this change could be attributed to
the play. For example, one participant explained this
change, “Ja, at first, but now they are accepting the fact
that they have TB. So they are starting to treat it, so it’s
not much of a problem,” and another said: “But now
everyone knows if you’re having TB, it can happen to
anyone. So no matter in which place you are or where
you’re from, they know that you can get TB.”
Post-drama focus group participants, some of whom
were different individuals from those interviewed before
the play, showed the same confidence in terms of their
rights and participation in research. Although one par-
ticipant expressed that she was tired of being asked
questions about TB, another intervened, with support
from others, that not everyone felt the same way. Partici-
pants went on to give their opinions about the play, “I
liked it because the play advised people” and “I was not
expecting the play to be in that way. They have made it
in a sort of interesting way whereby they try to make
sure that everyone wants to watch the play … because
then you learn stuff.”
Post-drama interviews
In addition to focus group discussions and identification
of themes from anecdotal materials by participants,
learner-actors took part in a feedback workshop about
their experiences in the play. Both learner-actors and
focus group participants agreed that the play had the
potential to impact the wider community if it were
rolled out, “Because most of the people out there in the
communities … so if they could see the play and under-
stand the play, I don’t think that everyone else would be
afraid to go to the clinic to test if they have TB.”
The feedback that emerged from the pre-drama focus
groups contributed to the learning of learner-actors.
Learner-actor feedback, after the plays had run, reflected
on gaps in their knowledge before their involvement in
the drama, revealing strikingly similar gaps as those
identified in pre-drama focus groups. Learner-actors also
shared that, besides improved knowledge of TB, they
learned new theories and applications of theatre from
the UCT student-actors and that health awareness can
be communicated through drama. Table 5 lists the re-
sponses of learner-actors in relation to what they learned
from their involvement in Carina’s Choice.
Feedback from SATVI staff revealed that the play
assisted recruitment because it sensitised the population
to the TB epidemic and TB vaccine research. School
staff were receptive to further contact with SATVI and
they arranged time slots for SATVI staff to recruit inter-
ested trial volunteers.
Table 5 Comments by learner-actors during post-drama
interviews
But the students from UCT taught us about image theatre – things that
we can use in our drama practical.
Now I don’t look at a production in the same way when I do my
practical.
It made me more reliable because I had to look after the props and
made sure that everything was okay.
I also learnt more about TB. You just hear about TB, but you don’t really
know how you get TB and how you can prevent it.
Yes, I’ve also learnt that you can teach other people new things by
showing it to them.
And drama gives you another view of the world. You will understand it
better when you see it.
I think the songs will stay with the people for a long time, and they
have learnt something from it.
Through this SATVI project I built up my self-confidence again.
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Discussion
As a method of engagement, the play worked. Carina’s
Choice increased awareness of TB and SATVI’s research
activities amongst school-attending adolescents in the
Worcester area. The continuous feedback process that
the research team attempted to foster with the drama
development team allowed for the inclusion of topics of
salience (for focus groups members) in the play’s script.
As is evident from post-drama discussions and interviews,
learner-actors and audience members remembered songs
from the play, and learner-actors became references for
TB questions within their own (self-identified) commu-
nities. Furthermore, the collaboration between UCT
Drama School and WSS was successful and both parties
expressed great enthusiasm for future projects as en-
couraged by the audience.
Through the larger process of engagement that this
collaboration, driven by the clinical trial site, is trying to
foster, striking information emerges about the ways in
which the young people involved in our focus groups
understand TB. Such information is a powerful tool in
understanding the social dimensions of TB in an area
with extremely high rates. Our focus group data reveal
an association of TB with HIV; this link creates new forms
of stigma. South Africa’s specific history in acknowledging
HIV and generations of death certificates claiming deaths
to be a result of TB while the presence of HIV was
ignored or at least not formally documented have added
to an already stigmatised ailment [11]. Confusion about
TB and HIV may additionally stem from the fact that the
two diseases are taught together in Life Skills Orientation
classes.
The original video-recording of the production as
well as versions with English and Xhosa subtitles will
be made available to SATVI’s collaborators in South
Africa, and within the Africa-wide TB Vaccine Sites
Network (TBVACSIN; coordinated from within SATVI).
Video copies will also be distributed to the Department of
Health as an educational tool for use in the Life Orienta-
tion programme. The video-recording may be adapted for
new environments, following input from collaborators
from these sites.
Limitations
This project aimed to engage school learners around TB
and clinical trial participation in a TB trial where the
focus of engagement was the development of the script
for the drama and the production of the performances.
This paper describes the efforts that contributed to the
development of the play, as part of the ongoing and pre-
liminary analysis built into the engagement project. The
majority of the project’s budget was dedicated to the
development of the play, and thus, the processual or
continuous evaluation methods described in this paper
were purposefully not the focus of the grant. While this
project aimed to fulfil a continuous method of analysis,
budgetary limitations did not allow for a social science
researcher to remain engaged and attend all proceedings
of the workshops aimed at developing the production. It
may be argued that convenience sampling of focus group
participants statistically reduced the generalisability of the
information shared during these sessions, but qualitative
methods adhere to a principle that if a theme arises, it is
pertinent, regardless of its frequency as a concern.
In addition, budgetary limitations meant that focus
group numbers and meetings had to be limited. As such,
a question raised at one pre-play focus group regarding
transmission of TB during pregnancy was not highlighted
as an important salient topic, but in post-play focus
groups it arose twice, making us flag it as a potentially
important future topic. That it arose initially as a concern
not high on our priority list of tasks to attend to, but then
again in post-play focus groups, shows both the value of
our continual assessment and review, and of incorporating
more focus group engagement if future iterations of this
type of engagement are going to take place. Ethnographic,
long-term and action-oriented research throughout this
process could provide valuable input on the experience of
the learner-actors to support educational research that
attributes benefits of the skill sets acquired through the
study of drama for empowering health-related decision-
making.
Conclusion
The play worked as a method of engagement. As the
assessment process and continuous engagement are cen-
tral to the method we have developed, we encourage
assessments similar to that used in the pilot phase, when
rolled out to other environments, and we will make our
questionnaires available for this purpose. We suggest
that this project may assist in creating a valuable en-
gagement tool for other trial communities, if used in
conjunction with context-specific assessment and con-
tinuous engagement for feedback on the intervention.
Appendix
Wie het vir julle gesé, Om in TB se pad te lé, (×2)
TB maak jou lam,
TB maak jou bang,
TB van n snies,
Laat gewig verlies, (×2)
Wie het vir julle gesé, Om in TB se pad te lé, (×2)
Haal asem my longe asem, Haal asem my longe asem,
Maak daai vensters oop, (hoes)
In jou elmboog, (hoes)
Wie het vir julle gesé, Om in TB se pad te lé, (×2 Wie
het; Wie Het/TB; TB)
…Hier kom daai koors,
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Hy kom om die hoek,
Jy moet lekka koes, (want)
Hy gaan jou verwoes.
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